Santhera Pharmaceuticals Holding AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Santhera Pharmaceuticals Holding AG with three other
pharmaceutical manufacturers in Europe:
Circassia Group PLC
of UNITED KINGDOM
sales of £62.40 million [US$79.39 million]
of which 55%
Bosnalijek d.d. Sarajevo
of BOSNIA and HERZEGOVINA
(144.23 million Bosnia & Herzegovina [US$85.34 million]
Cathay International Holdings Ltd
based in UNITED KINGDOM
(£62.35 million [US$79.33 million]
of which 68%
During the year ended December of 2019, sales at
Santhera Pharmaceuticals Holding AG were 75.38 million Swiss Francs (US$81.58 million).
increase of 138.1%
versus 2018, when the company's sales were 31.66 million Swiss Francs.
This was the fifth consecutive year of sales increases at Santhera Pharmaceuticals Holding AG
(and since 2014, sales have increased a total of 2,809%).